Clinical Trials Browser

Active not recruiting × enasidenib × Myeloid × Clear all

NCT03744390 2025-05-18

IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome

Phase 2 Active not recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute